Login / Signup

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.

Seiichiro MitaniKen KatoHiroyuki DaikoYoshinori ItoIsao NozakiTakashi KojimaMasahiko YanoSatoru NakagawaMasaki UenoMasaya WatanabeShigeru TsunodaTetsuya AbeShigenori KadowakiTomohiro KadotaKeita SasakiRyunosuke MachidaYuko Kitagawa
Published in: Journal of gastroenterology (2022)
The incidence of SPMs was high. The presence of LVLs, which was a predictive factor for SPMs, may be useful for surveillance planning.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • public health
  • risk factors
  • study protocol
  • double blind
  • placebo controlled
  • locally advanced
  • randomized controlled trial
  • radiation therapy